Evotec Announces Collaboration on Cellular Target Profiling
Evotec AG recently announced that Evotec and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, have entered into a research collaboration with the objective of leveraging Evotec’s advanced chemical proteomics services to support compounds in development at Dow AgroSciences. To this end, Evotec will perform quantitative chemical proteomics services (Cellular Target Profiling) to de-convolute phenotypic screening results obtained by Dow.
“We look forward to working with Dow AgroSciences on this project,” said Dr. Mario Polywka, Chief Operating Officer of Evotec. “This collaboration highlights the broad applicability of Evotec’s industry leading chemical proteomics platform to determine cellular target affinities and mechanisms of action on a proteome wide level and in a native context.”
“Dow AgroSciences is pleased to announce this new partnership with Evotec, an innovative leader in advanced chemical proteomics. This collaboration enhances Discovery’s technology tool-box to accelerate our efforts to deliver novel solutions to our customers around the world,” added Dr. William Kleschick, Discovery Global Leader of Dow AgroSciences.
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies. For more information, visit www.evotec.com.
Dow AgroSciences develops leading-edge crop protection and plant biotechnology solutions to meet the challenges of the growing world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of
$6.4 billion in 2012. For more information, visit www.dowagro.com.
Total Page Views: 964
